MedPath

The Influence of Warm Bupivacaine on Supraclavicular Plexus Block Characteristics

Not Applicable
Completed
Conditions
Surgery to the Distal One Third of the Upper Limb
Interventions
Registration Number
NCT03265886
Lead Sponsor
Mansoura University
Brief Summary

Despite PH adjustment of local anesthetic solution improves the quality of the block in all respects with special advantage of early onset of sensory and motor block, adequate level of analgesia, and prolongation of duration of block, the effect of warmed bupivacaine should have the same effect which have not been evaluated on supraclavicular plexus block for upper limb surgery.

The warmed bupivacaine used in supraclavicular plexus block may reduce sensory and motor block onset and prolong the duration of analgesia when compared to bupivacaine at operating room temperature.

Detailed Description

The aim of this study is to compare the effect of warm bupivacaine 0.5% at 37◦C versus bupivacaine 0.5% at operating room temperature at 23◦C on ultrasound-guided supraclavicular plexus block characteristics as regard sensory block onset time, motor block onset time, duration of sensory and motor block , effective duration of analgesia, total analgesics requirement, complications and side effects.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
90
Inclusion Criteria
  • American Society of Anesthesiologists physical class I or II
Exclusion Criteria
  • Patient refusal.
  • Pregnancy
  • Neuromuscular diseases (as myopathies, myasthenia gravies...)
  • Hematological diseases
  • Bleeding disorders
  • Coagulation abnormality.
  • Psychiatric diseases.
  • Local skin infection
  • Sepsis at site of the block.
  • Known intolerance to the study drugs.
  • Body Mass Index > 40 Kg/m2.
  • Bilateral upper limb injury to be performed at the same procedure.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Bupivacaine at operating room temperature (23°c)Bupivacaine at operating room temperature (23°c)Bupivacaine at temperature of 23°C will be administered
Warm bupivacaine at (37°c)Warm bupivacaine at (37°c)Warmed bupivacaine at body temperature will be administered
Primary Outcome Measures
NameTimeMethod
Time to onset of sensory blockfor 30 min following injection

defined as the time interval between the end of local anesthetic injection and the loss of sensation to pinprick (sensory score = 1)

Secondary Outcome Measures
NameTimeMethod
Heart rateFor 3 hours after the injection of local anesthetic
Duration of sensory blockFor 24 hours after the injection of local anesthetic

defined as the interval between end of injection and complete end of sensory block (score=2)

Satisfaction Scorefor 48 hrs after the injection of local anesthetic

Using score including 5-Excellent, 4-Very Good, 3-Good, 2-Fair, and 1-Poor

Blood pressureFor 3 hours after the injection of local anesthetic
The severity of postoperative painFor 24 hours after the injection of local anesthetic

will be measured and recorded by using a 100-cm visual analog scale (VAS) for pain, where 0 is equal to no pain and 100 indicates the worst possible pain.

Time to onset of motor blockFor 3 hours after the injection of local anesthetic

defined as time interval between the end of local anesthetic injection and (motor score = 1) in the distributions of all 4 peripheral nerves.

oxygen saturation in the peripheral bloodFor 3 hours after the injection of local anesthetic
Time for first analgesic requestFor 24 hours after the injection of local anesthetic

Time to the first receiving of rescue analgesic from the time of blockade

Duration of motor blockFor 24 hours after the injection of local anesthetic

defined as the interval between end of injection and complete recovery of normal motor function (score=0), respectively.

Total analgesics receivedfor 24 hrs after the injection of local anesthetic

Cumulative use of rescue analgesics after performing the blockade

Trial Locations

Locations (1)

Mansoura University, Faculty of Medicine

🇪🇬

Mansourah, DK, Egypt

© Copyright 2025. All Rights Reserved by MedPath